{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T06:26:02Z","timestamp":1784874362114,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.vaccine.2021.02.009","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T18:18:44Z","timestamp":1613672324000},"page":"1593-1597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A clinical audit of pneumococcal vaccination among patients with autoimmune rheumatic diseases living in Greece: The power of awareness"],"prefix":"10.1016","volume":"39","author":[{"given":"Costas A.","family":"Constantinou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios C.","family":"Ziogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliki","family":"Venetsanopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0530-3209","authenticated-orcid":false,"given":"Maria N.","family":"Gamaletsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loukia","family":"Koutsogeorgopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Barbouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios G.","family":"Tzioufas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos V.","family":"Sipsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.02.009_b0005","first-page":"958","article-title":"National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20-year follow-up study","volume":"30","author":"Thomas","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2021.02.009_b0010","doi-asserted-by":"crossref","first-page":"2287e93","DOI":"10.1002\/art.10524","article-title":"Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study","volume":"46","author":"Doran","year":"2002","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.vaccine.2021.02.009_b0015","first-page":"387","article-title":"The risk of hospitalized infection in patients with rheumatoid arthritis","volume":"35","author":"Smitten","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2021.02.009_b0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/berh.2001.0226","article-title":"Infectious diseases in systemic lupus erythematosus: risk factors, management and prophylaxis","volume":"16","author":"Fessler","year":"2002","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.vaccine.2021.02.009_b0025","doi-asserted-by":"crossref","first-page":"1078e85","DOI":"10.1002\/acr.22575","article-title":"Burden of serious infections in adults with systemic lupus erythematosus: a national population-based study, 1996e2011","volume":"67","author":"Tektonidou","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.vaccine.2021.02.009_b0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/shem.2002.31918","article-title":"Chronic neutropenia associated with autoimmune disease","volume":"39","author":"Starkebaum","year":"2002","journal-title":"Semin Hematol"},{"key":"10.1016\/j.vaccine.2021.02.009_b0035","doi-asserted-by":"crossref","first-page":"14447","DOI":"10.1073\/pnas.95.24.14447","article-title":"Perturbation of the T cell repertoire in rheumatoid arthritis","volume":"95","author":"Wagner","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2021.02.009_b0040","doi-asserted-by":"crossref","first-page":"9203","DOI":"10.1073\/pnas.97.16.9203","article-title":"T cell homeostasis in patients with rheumatoid arthritis","volume":"97","author":"Koetz","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2021.02.009_b0045","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/ard.2010.128637","article-title":"High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis","volume":"70","author":"Au","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2021.02.009_b0050","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofu024","article-title":"Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions","volume":"1","author":"Shea","year":"2014","journal-title":"Open Forum Infectious Diseases"},{"issue":"567","key":"10.1016\/j.vaccine.2021.02.009_b0055","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.3399\/bjgp09X472629","article-title":"Identification of new risk factors for pneumonia: population-based case-control study","volume":"59","author":"Vinogradova","year":"2009","journal-title":"Br J Gen Pract"},{"issue":"12","key":"10.1016\/j.vaccine.2021.02.009_b0060","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/jech-2011-200168","article-title":"Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses","volume":"66","author":"Wotton","year":"2012","journal-title":"J Epidemiol Commun Health"},{"key":"10.1016\/j.vaccine.2021.02.009_b0065","unstructured":"Pneumococcal vaccines WHO position paper \u2013 2012, http:\/\/www.who.int\/immunization\/policy\/position_papers\/pneumococcus\/en\/"},{"key":"10.1016\/j.vaccine.2021.02.009_b0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7326\/M17-3439","article-title":"Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States","volume":"168","author":"Kim","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.vaccine.2021.02.009_b0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00296-013-2907-9","article-title":"Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases","volume":"34","author":"Papadopoulou","year":"2014","journal-title":"Rheumatol Int"},{"issue":"April","key":"10.1016\/j.vaccine.2021.02.009_b0080","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.berh.2015.02.001","article-title":"Role of vaccinations and prophylaxis in rheumatic diseases","volume":"29","author":"Papadopoulou","year":"2015","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.vaccine.2021.02.009_b0085","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.vaccine.2015.01.065","article-title":"Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: Data from the international COMORA cohort","volume":"33","author":"Hmamouchi","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.02.009_b0090","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12891-016-1187-4","article-title":"A large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK","volume":"17","author":"Subesinghe","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.vaccine.2021.02.009_b0095","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.vaccine.2016.05.028","article-title":"Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: The key role of GPs in recommending vaccination","volume":"34","author":"Giese","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.02.009_b0100","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/03009742.2016.1242774","article-title":"Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA)","volume":"46","author":"Nguyen","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.vaccine.2021.02.009_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153848","article-title":"Influenza and pneumococcal vaccination uptake in patients with rheumatoid arthritis treated with immunosuppressive therapy in the UK: a retrospective cohort study using data from the clinical practice research datalink","volume":"11","author":"Costello","year":"2016","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2021.02.009_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032487","article-title":"Population Based Study of 12 Autoimmune Diseases in Sardinia, Italy: Prevalence and Comorbidity","volume":"7","author":"Sardu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.02.009_b0115","first-page":"1589","article-title":"Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study.The ESORDIG Study","volume":"30","author":"Andrianakos","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2021.02.009_b0120","unstructured":"Seoane-Mato D, et al. Prevalencia de enfermedades reum\u00e1ticas en poblaci\u00f3n adulta en Espana (estudio EPISER 2016). Objetivos y metodolog\u00eda. Reumatol Clin 2017"},{"key":"10.1016\/j.vaccine.2021.02.009_b0125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2474-11-98","article-title":"The prevalence of rheumatic diseases in central Greece: a population survey","volume":"11","author":"Anagnostopoulos","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.vaccine.2021.02.009_b0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00296-016-3608-y","article-title":"Low vaccination rates among patients with rheumatoid arthritis in a German outpatient clinic","volume":"37","author":"Krasselt","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.vaccine.2021.02.009_b0135","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jbspin.2010.10.012","article-title":"The uptake of influenza and pneumococcal vaccination among immunocompromised patients attending rheumatology outpatient clinics","volume":"78","author":"Haroon","year":"2011","journal-title":"Joint Bone Spine"},{"issue":"35","key":"10.1016\/j.vaccine.2021.02.009_b0140","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1016\/j.vaccine.2014.06.074","article-title":"Comparison of self-report influenza vaccination coverage with data from a population based computerized vaccination registry and factors associated with discordance","volume":"32","author":"Jim\u00e9nez-Garc\u00eda","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.02.009_b0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.vaccine.2021.02.009_b0150","doi-asserted-by":"crossref","first-page":"2845617","DOI":"10.1155\/2016\/2845617","article-title":"Vaccination of Adult Patients with Systemic Lupus Erythematosus in Portugal","volume":"2016","author":"Moraes-Fontes","year":"2016","journal-title":"Int J Rheumatol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21001572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21001572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:53:35Z","timestamp":1759402415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21001572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0264410X21001572"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.02.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A clinical audit of pneumococcal vaccination among patients with autoimmune rheumatic diseases living in Greece: The power of awareness","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}